Buntyn J, Carroll J, Smith T, Rivera J, Sanchez NB, Broadway P, Falkenberg S and Schmidt T
Livestock Science. 2016;188:103-110
DOI: https://doi.org/10.1016/j.livsci.2016.04.013
This study evaluated the effect of genetic selection for markers related to marbling deposition in Angus heifers on the immune response following a lipopolysaccharide (LPS) challenge. Fall-born heifers (n=19; ~7 months of age, 274±24 kg) with genetic variation for marbling were utilized including 10 heifers with no genetic markers (No-MVP) and 9 heifers with ≥1 markers (1+MVP). Genotypic variation for quantitative trait loci QG1 and QG2 heifers was determined. Twenty-four hour (h) prior to the LPS challenge, heifers were fitted with jugular catheters and vaginal temperature (VT) monitoring devices. Temperature monitoring devises were programed to record VT in 1 min intervals. On day (d) 0, 2 h prior to LPS challenge and 8 h post challenge, serum was collected in 0.5 h intervals (0800–1800 h). Serum was also collected at 12, 16, 20, and 24 h post LPS challenge. The LPS challenge was administered to the heifers at 1000 h via intravenous bolus (0.5 μg/kg BW). Serum was analyzed for cortisol, TNF-α, IL-6, IFN-γ, and haptoglobin (HAPT). A treatment×time interaction existed (P≤0.001) for VT; prior the LPS challenge, VT was similar. Vaginal temperature was elevated from 6 to 21 h post-LPS in 1+MVP compared to No-MVP. A treatment×time interaction (P=0.02) was observed for IFN-γ. Prior to the LPS challenge, IFN-γ concentrations were similar between the two groups. However, 3.5–7 h post-LPS concentrations of IFN-γ were greater (P≤0.05) for 1+MVP compared to No-MVP. There was no treatment effect (P≥0.17) for cortisol, TNF-α or IL-6. A treatment effect (P=0.02) was observed for HAPT; 1+MVP had decreased HAPT compared to No-MVP. Overall, results suggest that heifers selected based upon genetic markers for marbling may have an altered immune in response when challenged with LPS.
Neurology
Poster Background Developing effective therapies for glioblastoma (GBM) relies on robust preclinical animal models that enable detailed investigation of tumor biology, discovery of therapeutic targets, and evaluation of new treatment…
Oncology
Poster Background Ultrahigh-Plex Single-cell Spatial Phenotyping has revealed valuable insights into the tumor immune microenvironment (TiME) for biomarker discovery and stratification of clinical responses. Metabolic reprogramming is a key hallmark…
Neurology
Alzheimer’s Research and Therapy | August 26, 2024 Sampani K, Ness S, Tuz-Zahra F, Aytan N, Spurlock EE, Alluri S, Chen X, Siegel NH, Alosco ML, Xia W, Tripodis Y,…
Neurology
Poster The intersection of new therapeutic options for Alzheimer’s disease (AD), the emergence of accurate blood-based tests for AD, and the anticipated health system log jam for confirmatory diagnostic testing…
Neurology
Alzheimer’s & Dementia | August 3, 2024 Verberk IMW, Jutte J, Kingma MY, Vigneswaran S, Gouda MMTEE, van Engelen MP, Alcolea D, Arranz J, Fortea J, Lleó A, Chevalier C,…
Neurology
Journal of Lipid Research | August 2, 2024 Becktel DA, Frye JB, Le EH, Whitman SA, Schnellmann RG, Morrison HW, Doyle KP. J Lipid Res. 2024 https://doi.org/10.1016/j.jlr.2024.100614 Abstract Ischemic stroke…
